IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes.
Since IL-10 has recently been shown to exhibit pleiotropic effects on human monocytes, it was of interest to determine the effect of this cytokine on prostaglandin E2 (PGE2) production by monocytes. Recombinant IL-10 (rIL-10) did not significantly affect PGE2 production by lipopolysaccharide (LPS)-unstimulated monocytes, but efficiently inhibited PGE2 production by LPS-stimulated monocytes. The inhibition by rIL-10 was achieved in a dose-dependent manner. Recombinant IL-4 also inhibited PGE2 production at the same degree as rIL-10. Viral IL-10 inhibited PGE2 production by monocytes in a similar fashion as did human rIL-10. Endogenously produced IL-10 was also shown to inhibit PGE2 production by LPS-stimulated monocytes. Kinetic studies showed that the inhibition by rIL-10 on PGE2 production was observed at least 3 h after LPS stimulation. Taken together, these results indicate that IL-10 may play an important role in modulating immunological responses via down-regulation of PGE2 production by monocytes.
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
H
H
Niiro
T
T
Otsuka
S
S
Kuga
Y
Y
Nemoto
M
M
Abe
N
N
Hara
T
T
Nakano
T
T
Ogo
Y
Y
Niho
D002478:Cells, Cultured; D015232:Dinoprostone / Q000096:biosynthesis*; D006801:Humans; D016753:Interleukin-10 / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors*; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism
D008070:Lipopolysaccharides; D016753:Interleukin-10; D015232:Dinoprostone